Coronavirus (COVID-19) Information
Support for our patients with ADHD or adult B.E.D. during COVID-19
Takeda recognizes the immense concern related to COVID-19, and we are here to support our patients during this time.
Patient safety is Takeda's highest priority. As a company, we are committed to taking steps to keep the communities we serve updated with any new information that could help inform health decisions related to our medicines.
If you are currently taking Vyvanse, we strongly encourage you to stay in contact with your healthcare provider and to make use of any virtual or remote services that may be offered. You may also call our Medical Information Line at 1-800-828-2088 for questions regarding your medication.
For adults with ADHD: For information on savings and paying for your medication, please click here.
For the parents of children (6+) with ADHD: For information on savings and paying for your child's medication, please click here.
For adults with moderate to severe Binge Eating Disorder (B.E.D.): For information on savings and paying for your medication, please click here.
For the latest updates and news about Takeda and COVID-19, including information about the supply of Vyvanse, please click here.
The following resources may provide further helpful information during this time:
- For adult patients and children (6+) with ADHD: Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD)
- For adult patients with moderate to severe B.E.D.: National Eating Disorders Association (NEDA)
- For further information about ADHD and B.E.D.: